US$ 20.65
glp-1 and ibd Gut Hormones Inflammatory Bowel Disease SAFETY AND CLINICAL EFFECTIVENESS OF
Description
Peptides (1981) 2:414

These are not magic tricks

Fralick M, Schneeweiss S, Patorno E (2017) Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor
Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives

Durability of histological response and rebound effects A critical unresolved question concerns the durability of histological improvement following treatment interruption or dose reduction

Abbreviations: RCT: randomized clinical trial, BBR: berberine, RIAIS: Radiation-induced acute intestinal symptoms, RILI:radiation-induced lung injury
